These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21602499)

  • 1. Science to practice: Can T1rho imaging be used to diagnose and assess the severity of hepatic fibrosis?
    Sirlin CB
    Radiology; 2011 Jun; 259(3):619-20. PubMed ID: 21602499
    [No Abstract]   [Full Text] [Related]  

  • 2. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model.
    Wang YX; Yuan J; Chu ES; Go MY; Huang H; Ahuja AT; Sung JJ; Yu J
    Radiology; 2011 Jun; 259(3):712-9. PubMed ID: 21436087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of liver disease: which option is right for my patient?
    Bhogal H; Sterling RK
    Infect Dis Clin North Am; 2012 Dec; 26(4):849-61. PubMed ID: 23083819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance elastography in the diagnosis of hepatic fibrosis.
    Godfrey EM; Mannelli L; Griffin N; Lomas DJ
    Semin Ultrasound CT MR; 2013 Feb; 34(1):81-8. PubMed ID: 23395320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of liver fibrosis: a concise review.
    Afdhal NH; Nunes D
    Am J Gastroenterol; 2004 Jun; 99(6):1160-74. PubMed ID: 15180741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging diagnosis of cirrhosis and chronic hepatitis.
    Ito K; Mitchell DG
    Intervirology; 2004; 47(3-5):134-43. PubMed ID: 15383722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging hepatic fibrosis: computer-aided analysis of hepatic contours on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced hepatocyte-phase magnetic resonance imaging.
    Goshima S; Kanematsu M; Kobayashi T; Furukawa T; Zhang X; Fujita H; Watanabe H; Kondo H; Moriyama N; Bae KT
    Hepatology; 2012 Jan; 55(1):328-9. PubMed ID: 21932401
    [No Abstract]   [Full Text] [Related]  

  • 8. Shall we bury the sword? Imaging of hepatic fibrosis.
    Talwalkar JA
    Gastroenterology; 2006 Dec; 131(6):1669-71. PubMed ID: 17188958
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative study of diffusion-weighted magnetic resonance imaging and pathological findings of liver fibrosis in rabbits].
    Wang QS; Zou Y; Liu H; Liu ZY; Liang CH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):1965-8. PubMed ID: 19861242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging in chronic liver disease evaluated in relation to hepatic fibrosis--clinical and experimental results.
    Ohno A; Ohta Y; Ohtomo K; Hirata K; Takatsuki K; Mochida S; Ogata I; Itai Y; Iio M; Fujiwara K
    Radiat Med; 1990; 8(5):159-63. PubMed ID: 2075231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to assess liver fibrosis and for what purpose?
    Beaugrand M
    J Hepatol; 2006 Mar; 44(3):444-5. PubMed ID: 16426699
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron-containing nodules of cirrhosis.
    Zhang J; Krinsky GA
    NMR Biomed; 2004 Nov; 17(7):459-64. PubMed ID: 15526293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive markers of liver fibrosis in Latin America and Mexico.
    Uribe M; Gutiérrez-Grobe Y; Kobashi-Margáin RA; Méndez-Sánchez N
    Ann Hepatol; 2010; 9 Suppl():43-8. PubMed ID: 20713995
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Invest Radiol; 2012 Nov; 47(11):649-55. PubMed ID: 23011189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of hepatic fibrosis: what is the role of non-invasive markers in 2003?].
    Mallat A; Dhumeaux D
    Gastroenterol Clin Biol; 2003 Apr; 27(4):367-70. PubMed ID: 12759674
    [No Abstract]   [Full Text] [Related]  

  • 16. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis: non-invasive assessment with MR elastography.
    Huwart L; Peeters F; Sinkus R; Annet L; Salameh N; ter Beek LC; Horsmans Y; Van Beers BE
    NMR Biomed; 2006 Apr; 19(2):173-9. PubMed ID: 16521091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis.
    Poordad FF
    Expert Rev Mol Diagn; 2004 Sep; 4(5):593-7. PubMed ID: 15347253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis.
    Cobbold J; Lim A; Wylezinska M; Cunningham C; Crossey M; Thomas H; Patel N; Cox J; Taylor-Robinson S
    Hepatology; 2006 Jun; 43(6):1401-2; author reply 1402. PubMed ID: 16729323
    [No Abstract]   [Full Text] [Related]  

  • 20. MR elastography to assess liver fibrosis.
    Carrión JA; Navasa M; Forns X
    Radiology; 2008 May; 247(2):591; author reply 591-2. PubMed ID: 18430886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.